Daniel Levy

Phoenix Pharmalabs, Inc.

NIH Rank #1908
  • Program Leader
  • Top 10% Funded
  • Early Career

NIH Funding · FY2024

Total Funding
$3.6M
Fiscal year 2024
Grants Awarded
1
Active NIH grants
National Rank
#1,908
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $3.6M across 1 grant · National rank #1908.

Top grants by award amount

Daniel Levy's NIH grant portfolio, ranked by award amount.

  • 5U01DA057862-03U01
    Development of PPL-138, a Novel Mixed NOP/Mu Partial Agonist for Treatment of CocaineUse Disorder
    $3.6M
    award amount

Affiliation

Institutions that have administered grants for Daniel Levy.

Affiliated with Phoenix Pharmalabs, Inc. (UT).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Phoenix Pharmalabs, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1908
  6. 2024
    Entered Top 25% Nationally
    Ranked #1908
  7. 2024
    Entered Top 10% Nationally
    Ranked #1908

Related investigators

Other NIH-funded PIs frequently associated with Daniel Levy.